Previous 10 | Next 10 |
Notice of Allowance Issued for Central Nervous System Peptide Technology AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients PR Newswire NEW YORK , July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AI...
AIkido Pharma ([[AIKI]] -0.8%) provided an update to the progress of its antiviral platform with the University of Maryland School of Medicine.As part of the project, scientists have identified 4 lead compounds that block Influenza, Coronavirus ((CoV-2)), and Ebolavirus replication, the compa...
AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland Work on Coronavirus, Influenza and Ebolavirus Advances Computer Aided Drug Design Accelerates Development PR Newswire NEW YORK , July 16, 2021 /PRNewswire/ -- AIkido Ph...
AIkido Pharma to Attend the Alzheimer's Association International Conference PR Newswire NEW YORK , July 13, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced it will attend the Alzheimer's Association In...
AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease ~ Invention Seeks to Combine Psychedelics with Peptides to Treat Disease PR Newswire NEW YORK , June 23, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("...
AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 - Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients - Phase 2 Trial Underway PR Newswire NEW YORK , June 4, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nas...
AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Meeting - Data to be Presented June 4, 2021 - Abstract Indicates Tolerability and Early Evidence of Clinical Activity PR Newswire NEW YORK , Ma...
Marathon Digital Holdings (MARA) -12%.Onconova Therapeutics (ONTX) -11%.Iovance Biotherapeutics IOVA -11% after lifileucel regulatory timeline update.Ebang International (EBON) -10%.Riot Blockchain (RIOT) -9%.U.S. Well Services (USWS) -9%.Canaan (CAN) -9%.The9 (NCTY) -8%.Purple Inno...
New York, New York--(Newsfile Corp. - May 19, 2021) - PCG Digital -- Continuing the barrage of good-news announcements that began with its first quarter results and strong balance sheet reports, Alkido Pharma Inc . (NASDAQ: AIKI) was recently highlighted in two key investor features. A biotec...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The recent hype seen for Reddit penny stocks may not be coming back. Retail speculation in “meme stocks” is out and dabbling in cryptocurrencies is in. In short, overall enthusiasm is no longer enough to sen...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...